Benefits of Early Impurity Analysis to Pharmaceutical R&D

August 27, 2013
We presented two/ posters at the CoSMoS 2013 (Conference on Small Molecule Spectroscopy) in San Diego this month. This poster titled Why Bother with the Little Peaks? Benefits of Early Impurity Analysis to Pharmaceutical R&D is a case study exploring the effectiveness of SFC in isolating impurities from complex mixtures or bulk compound samples.
It’s become customary to identify minor impurities late in the process of drug development. Partly this is because the FDA doesn’t require a complete suite of information until the drug is close to the approval stage, but partly it’s because this work is time-consuming and demanding of analytical resources.
Suppose impurity isolation and characterization could be efficiently and inexpensively accomplished early in compound development. Opportunities could arise to:
*The other poster presented at CoSMoS in 2013 – Targeted Isolation of Impurities in Pharmaceutical Compounds using SFC
Developing and Validating an HPLC Method February 20, 2019 A host of resources must be harnessed to bring a drug… Read more
Understanding the Importance of Stress Degradation Studies December 4, 2018 “Frequently time is of the essence. It is necessary to… Read more
Mass Balance – What, When, How? July 10, 2018 This “fishbone diagram”, shown by permission from Steven Baertschi (S. W.… Read more
A Better Way to Look at Risk/Reward During Early Drug Development? Jeff Kiplinger October 16, 2015 How do you add… Read more
Method Development and Validation – Are We Doing It Right? April 21, 2015 Last year, a group of academic chromatographers… Read more
Looking at Impurity Isolation Early Can Benefit Your Drug Development Process July 18, 2014 Jeffrey Kiplinger, President and Founder of… Read more
Targeted Isolation of Impurities in Pharmaceutical Compounds using SFC August 30, 2013 We presented two* posters at CoSMoS 2013, Targeted Isolation™ of… Read more
Averica Wins Silver at 2013 CoSMoS Olympics for Chemistry Development August 14, 2013 Our chemistry method development (in collaboration with Novatia,… Read more
Using Chiral SFC/MS to Solve a Bioanalysis Problem November 29, 2012 We were asked recently to participate in a technology… Read more
Chiral Biotransformation Analysis in Rat Plasma by SFC August 31, 2012 A compound developed in a pharmaceutical lead optimization project… Read more